Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Bioactivation and Tissue Toxicity

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exposure limits to radiofrequency EMF do not account for cancer risk or reproductive toxicity assessed from data in experimental animals.

Environmental health : a global access science source·2026

Same author

The WHO-commissioned systematic reviews on health effects of radiofrequency radiation provide no assurance of safety.

Environmental health : a global access science source·2025

Same author

The Systematic Review on RF-EMF Exposure and Cancer by Karipidis et al. (2024) has Serious Flaws that Undermine the Validity of the Study's Conclusions.

Environment international·2024

Same author

COSMOS: A methodologically-flawed cohort study of the health effects from exposure to radiofrequency radiation from mobile phone use.

Environment international·2024

Same author

Cell Phone Radiation Exposure Limits and Engineering Solutions.

International journal of environmental research and public health·2023

Same author

Artificial Selection on Microbiomes To Breed Microbiomes That Confer Salt Tolerance to Plants.

mSystems·2021

Search research articles

Related Experiment Video

Updated: May 22, 2026

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

MTBE: recent carcinogenicity studies.

Kathleen M Burns¹, Ronald L Melnick

¹Sciencecorps, MA, USA. info@sciencecorps.org

International Journal of Occupational and Environmental Health

|May 4, 2012

Summary

This summary is machine-generated.

Methyl tert-butyl ether (MTBE) in drinking water poses health risks. Recent studies confirm its carcinogenicity, including brain tumors, despite industry claims otherwise, highlighting the need to assess environmental chemical risks.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Experiment Videos

Last Updated: May 22, 2026

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Area of Science:

Environmental Science
Toxicology
Public Health

Background:

Methyl tert-butyl ether (MTBE), a common gasoline additive, has been a persistent contaminant in drinking water supplies for decades.
Early carcinogenicity studies in the 1990s indicated potential human health risks associated with MTBE exposure.
Concerns persist regarding the long-term health implications of widespread MTBE contamination.

Purpose of the Study:

To summarize recent findings on MTBE carcinogenicity.
To evaluate the totality of carcinogenic effects and health risks posed by MTBE.
To contextualize industry-sponsored studies and their interpretation of MTBE's health impacts.

Main Methods:

Review of recent animal carcinogenicity studies on MTBE.
Analysis of tumor induction sites, including newly identified areas like the brain.
Comparative assessment of findings from independent and industry-sponsored research.

Main Results:

Recent studies confirm the carcinogenic effects of MTBE in animal models.
Additional tumor induction sites, such as the brain, have been identified.
Industry-sponsored research has attempted to downplay or refute the significance of these findings for human health.

Conclusions:

The evidence confirms MTBE's carcinogenic potential and associated health risks.
Contradictory interpretations by the petroleum industry warrant critical evaluation.
A comprehensive understanding of MTBE's risks is crucial for public health protection.